[Evolvement of hormone therapy for breast cancer. Florence, March 14, 2001].
Longo
F
F
Oncologia Medica, Policlinico Umberto I, Roma.
Mansueto
G
G
D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology*; D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D020847:Estrogen Receptor Modulators / Q000494:pharmacology*; D005260:Female; D006801:Humans; D009570:Nitriles / Q000494:pharmacology; D016032:Randomized Controlled Trials as Topic; D013256:Steroids / Q000494:pharmacology; D016896:Treatment Outcome; D014230:Triazoles / Q000494:pharmacology
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D004791:Enzyme Inhibitors; D020847:Estrogen Receptor Modulators; D009570:Nitriles; D013256:Steroids; D014230:Triazoles; D000077384:Anastrozole
L'evoluzione dell'ormonoterapia nelle attuali strategie di trattamento del carcinoma mammario. Firenze, 14 marzo 2001.